| Dr Robert David Benavides, PHARM D | |
|
604 Kingstown Rd, Wakefield, RI 02879-3612 | |
| (401) 783-4250 | |
| Not Available |
| Full Name | Dr Robert David Benavides |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 604 Kingstown Rd, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184051724 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH05251 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert David Benavides, PHARM D 604 Kingstown Rd, Wakefield, RI 02879-3612 Ph: (401) 783-4250 | Dr Robert David Benavides, PHARM D 604 Kingstown Rd, Wakefield, RI 02879-3612 Ph: (401) 783-4250 |
News Archive
There's a wealth of health information hiding in the human immune system. Accessing it, however, can be very challenging, as the many and complex roles that the immune system plays can mask the critical information that is relevant to addressing specific health issues.
People of color in the United States typically have 15 percent of the net worth of their white counterparts, according to the Insight Center for Community Economic Development.
In the United States, approximately 179 million cases of acute diarrhea occur each year, and most of those cases are entirely preventable, a researcher from The University of Texas Health Science Center at Houston concluded in a New England Journal of Medicine review article.
POZEN Inc., a pharmaceutical company committed to transforming medicine that transforms lives, announced today the results of a Phase 1 study, which reported that PA32540, a novel coordinated-delivery tablet of enteric-coated aspirin (325 mg) and immediate-release omeprazole (40 mg), showed no ex vivo drug-drug interaction with clopidogrel when administered 10 hours apart in healthy patients, based on the study's pre-specified analysis.
The signaling molecule CD95L, known as "death messenger," causes an inflammatory process in injured tissue after spinal cord injuries and prevents its healing. This discovery was published by scientists of the German Cancer Research Center. In mice, the researchers found out that if they switch off CD95L, the injured spinal cord heals and the animals regain better ability to move. Therefore, substances which block the death messenger might offer a new approach in the treatment of severe inflammatory diseases.
› Verified 3 days ago
Ryan Patrick Kelley, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 203 Main St, Wakefield, RI 02879 Phone: 401-307-2555 Fax: 401-783-0045 | |
Sherry Lynn Manferdini, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 Main St, Wakefield, RI 02879 Phone: 401-783-3384 | |
Dr. Todd Estus, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 71 Paul Ave, Wakefield, RI 02879 Phone: 401-218-3014 | |
Alexander Balkum, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 Main St, Wakefield, RI 02879 Phone: 401-783-3384 | |
Vimal S. Patel, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 604 Kingstown Rd, Wakefield, RI 02879 Phone: 401-783-8630 Fax: 401-783-9080 | |
Kristen St Jean, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11 Main St, Wakefield, RI 02879 Phone: 401-783-3384 |